Analyst Recommendations

5.17 0.11(2.17%)10/04/2024
Inozyme Pharma Inc (INZY)


2024: Total Recommendations Consensus
To Grade# of Recommendations
Buy9
Outperform3

5 records were shown. To view all data, Upgrade to PRO plan with only $1


Upgrades & Downgrades